How Much Did Pivot Bio Raise? Headquarters, Funding & Key Investors

Pivot Bio has raised USD $ 750,000 in Seed, USD $16 million in Series A, USD $71.3 million in Series B, USD $100 million in Series C, and USD $430 million in Series D, totaling approximately USD $618 million in funding. The latest $430 M round in July 2021 valued the company at about USD $2 billion. Founded in 2010, Pivot Bio provides microbe-based nitrogen-fixing solutions for crops. These funds will be used to scale their biological nitrogen fixation products across major agricultural markets, expand manufacturing, and accelerate the global rollout of sustainable crop nutrition technologies.

How Much Did Pivot Bio Raise? Funding & Key Investors

Pivot Bio, founded in 2010, is a Berkeley-based (United States) crop tech and genomics company. It develops microbe-based nitrogen-fixing solutions for crops, providing farmers with sustainable, high-performing alternatives to synthetic fertilizers. Pivot Bio employs around 256 people and focuses on delivering predictable crop nutrition using engineered microorganisms compatible with diverse soil types, weather, and topography. Its platform supports commercial agriculture, aiming to improve productivity, reduce environmental impact, and expand globally with research-driven innovations in microbial crop nutrition.

What Is Pivot Bio and What Does It Do?

Pivot Bio, founded in 2010, is a Berkeley-based (United States) Crop Tech / Genomics company.

With a team of approximately 256 employees as of December 2022, it develops microbe-based crop nutrition products that deliver nitrogen to plants via biological nitrogen fixation, specifically using engineered microorganisms that form symbiotic relationships with corn roots, fixing atmospheric nitrogen directly in the field and eliminating or reducing the need for synthetic nitrogen fertilisers.

The company uses an in-furrow method of application, and its solution is designed to perform regardless of topography, weather or soil type, serving farmers seeking both increased productivity and sustainability.

How Much Funding Has Pivot Bio Raised?

1. Seed

Amount Raised: $0.75 M
Date: October 2014
Lead Investors: DCVC, Monsanto Growth Ventures (Seed stage)
Motivation: To initiate the development of microbe-based nitrogen solutions.

2. Series A

Amount Raised: $16 M
Date: January 2016
Lead Investors: DCVC, Prelude Ventures, Monsanto Growth Ventures
Motivation: Commercialize first-generation microbial nitrogen solution for corn.

3. Series B

Amount Raised: $71.3 M
Date: October 2018
Lead Investors: Breakthrough Energy Ventures, Temasek
Motivation: Expand R&D, begin commercial rollout in the U.S., and entry into new markets.

4. Series C

Amount Raised: $100 M
Date: May 2020
Lead Investors: Temasek, Breakthrough Energy, DCVC, Prelude Ventures, Pavilion Capital Partners
Motivation: Scale production, expand product portfolio, and global presence.

5. Series D

Amount Raised: $430 M
Date: July 2021
Lead Investors: DCVC, Temasek, Generation Investment Management, G2VP
Motivation: Accelerate growth, scale manufacturing, and global market expansion.

Total Funding Raised: $618 Million

Current Valuation: $2 Billion (as of September 2021)

Latest Funding Date: July 2021

Key Investors

1. Generation Investment Management

Details: London-based investment firm co-founded by Al Gore, focusing on sustainable investments.
Investment Focus Areas: Climate tech, sustainable agriculture, clean energy infrastructure.
Notable Investments: Pivot Bio, Beyond Meat, TerraCycle.

2. Temasek

Details: Singapore sovereign wealth fund, active globally across sectors.
Investment Focus Areas: Technology, sustainability, life sciences, and agriculture.
Notable Investments: Pivot Bio, Klarna, Grab.

3. DCVC (Data Collective Venture Capital)

Details: U.S. VC firm specialising in deep tech, biotech, and frontier science.
Investment Focus Areas: Microbiology, AI, advanced materials, and sustainable agriculture.
Notable Investments: Pivot Bio, Grammarly, Planet Labs.

Where Is Pivot Bio’s Headquarters?

Pivot Bio is headquartered in Berkeley, California, United States. This location places the company in proximity to major biotech research institutions (including UC Berkeley), a strong talent pool in life sciences and engineering, and vibrant venture capital ecosystems focused on climate tech and ag-tech.

What’s Next for Pivot Bio?

Pivot Bio aims to scale its microbial nitrogen-fixing platform from corn to other staple crops, such as wheat and rice, expand its manufacturing footprint, and grow international distribution beyond the U.S. The company faces challenges, including regulatory approvals in new geographies, competition from conventional fertiliser incumbents, and the need to educate farmers on the adoption of new microbial solutions.

Get Investor & Funding Insights with TexAu

TexAu helps sales and business teams uncover detailed fundraising information on companies like Pivot Bio. Use the platform to research investors, track funding rounds, and gather actionable insights to strengthen prospecting and business strategy.